Why Invest

We develop products and solutions that make life better – and have been successfully doing so for over 300 years. And when you’ve prospered for centuries as we have, you must have done a few things right.

It’s a great idea to invest in us – and here’s why

  • Poised for long-term growth; building on attractive mega trends in Life Science, Healthcare and Electronics
  • Resilient and high-quality cashflow profile; reliable cash generation leveraging multi-industry set up
  • Strong M&A track record enhanced by rapid deleveraging
  • Bringing innovation faster to patients and customers, contributing to their sustainability efforts
2023 Q4 Report - At a Glance

Related News

View All News
  1. Press Releases

    Future Insight Prize 2024 Awarded to Johns Hopkins University’s Lauren Gardner

    We awarded Lauren Gardner, representing Johns Hopkins University, Baltimore, USA, with the Future Insight Prize 2024 worth 500.000 € today.

    2024/07/10

  2. Press Releases

    MilliporeSigma Announces Non-Binding MoU with Afrigen Biologics for Development ...

    The Life Science business of Merck KGaA, Darmstadt Germany entered into a non-binding Memorandum of Understanding (MoU) with Afrigen Biologics to support the development of an mRNA vaccine technology plattform.

    2024/07/03

  3. Press Releases

    Merck KGaA, Darmstadt, Germany, Provides Update on Xevinapant Program in Locally ...

    Merck KGaA, Darmstadt, Germany, today announced the discontinuation of the Phase III randomized TrilynX study.

    2024/06/24

investors-shareprice2 investors-shareprice2
Share Price
Check Share Price
Share Price
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
453077651 453077651
Financials
Read More
Financials
Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.